news aktuell GmbHnews aktuell GmbH

IFCO Systems: IFCO European Lift Lock containers become Cradle to Cradle Certified® Silver

Share
The Lift Lock range in Europe is the first and only reusable food packaging container range with this prestigious sustainability certification

(Munich, Germany): The leading global provider of reusable packaging for fresh foods, IFCO, has had its European line of Lift Lock reusable plastic containers (RPCs) awarded Cradle to Cradle Certified® (Version 3.1) at the Silver level. IFCO’s European Lift Lock products are now the first and only fresh-food RPCs to meet this ambitious sustainability standard.

“Cradle to Cradle Certified gives leading companies a globally recognized standard for ensuring their impact on people and our planet is a positive one,” said Dr. Christina Raab, vice president of strategy and development for the Cradle to Cradle Products Innovation Institute. “IFCO is paving the way towards a new business model for safe, circular, and responsibly made food packaging.”

In addition to the overall Silver certification, the Lift Lock range was awarded Gold achievement level in the assessment category of Material Reutilization.

“We couldn’t be prouder of this accomplishment,” said IFCO Group CEO Michael Pooley. “We are committed to sustainability, and that means reusing materials as much as possible. And Cradle to Cradle goes beyond reducing negative effects on the environment. It’s about making a positive ecological impact. Repairing containers and reusing materials instead of throwing them away is a fundamental part of our circular economy business model.”

IFCO’s Lift Lock range includes products optimized for fruit and vegetables, meat, and baked goods. All IFCO products are shared and reused.

Please find the full announcement as well as images here.

Contacts

Daniela Carbone
VP - Global Marketing
Daniela.Carbone@ifco.com

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release

Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized

Digital Subsidiary of Austrian State Printing Company Wins Infrastructure Tender for German EU Digital Identity Wallet22.12.2025 15:12:30 CET | Press release

youniqx Identity, a digital subsidiary of the Austrian State Printing Company (OSD), has won a Europe-wide tender, together with partner companies, for the infrastructure of the German EU Digital Identity Wallet (EUDI-Wallet). EU member states are required by EU regulations to provide a national version of an EU-wide valid EUDI-Wallet by the end of 2026. Citizens will be able to use the EUDI-Wallet to prove their personal identity throughout the EU

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye